RD3-0028

• Description :

  RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM.

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  RSV

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/RD3-0028.html

• Solubility :

  10 mM in DMSO

• Smiles :

  C12=CC=CC=C1CSSC2

• Molecular Formula :

  C8H8S2

• Molecular Weight :

  168.28

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Watanabe W, et al. Novel anti-respiratory syncytial (RS) viral compounds: benzodithiin derivatives. Biochem Biophys Res Commun. 1998 Aug 28;249 (3) :922-6.|[2]Sudo K, et al. Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. Antimicrob Agents Chemother. 1999 Apr;43 (4) :752-7.|[3]Sudo K, et al. Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [3886-39-3]